The DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.
Targeted delivery of proapoptotic peptides to tumor-associated macrophages improves survival
Open accessAbstract
Significance: Tumor-associated macrophages (TAMs) are cells of our innate immune system that have been associated with poor prognosis in many types of cancers. When polarized toward the anti-inflammatory state, TAMs promote immune evasion and angiogenesis, thereby driving tumor growth. Using a peptide library selection strategy, we identified a sequence, called M2pep, that preferentially binds to anti-inflammatory murine macrophages. We then used M2pep to carry a proapoptotic peptide to TAMs by i.v. delivery and demonstrated that selective reduction of TAMs resulted in improved survival in tumor-bearing mice. These results suggest that a molecular-targeting approach for TAM depletion is a promising adjunct strategy to add to the arsenal of anticancer therapies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
RETRACTED: Suppressors of Cytokine Signaling 2 and 3 Diametrically Control Macrophage Polarization
Spence, S., Fitzsimons, A., Boyd, C. R., Kessler, J., Fitzgerald, D. C., Elliott, J., Gabhann, J. N., Smith, S., Sica, A., Hams, E., et al. (2012) · Immunity · doi:10.1016/j.immuni.2012.09.013 · Cited by 110
RetractedMantovani, A., Allavena, P., Sica, A., & Balkwill, F. (2008) · Nature · doi:10.1038/nature07205 · Cited by 11,399
Exploring the full spectrum of macrophage activation
Mosser, D. M., & Edwards, J. P. (2008) · Nature Reviews Immunology · doi:10.1038/nri2448 · Cited by 9,144
Macrophage plasticity and polarization: in vivo veritas
Sica, A., & Mantovani, A. (2012) · Journal of Clinical Investigation · doi:10.1172/jci59643 · Cited by 6,335
Alternative activation of macrophages
Gordon, S. (2003) · Nature Reviews Immunology · doi:10.1038/nri978 · Cited by 6,189
Monocyte and macrophage heterogeneity
Gordon, S., & Taylor, P. R. (2005) · Nature Reviews Immunology · doi:10.1038/nri1733 · Cited by 5,190
Alternative Activation of Macrophages: An Immunologic Functional Perspective
Martinez, F. O., Helming, L., & Gordon, S. (2009) · Annual Review of Immunology · doi:10.1146/annurev.immunol.021908.132532 · Cited by 2,745 · cited 2×
“Increased macrophage polarization to the M2 phenotype is associated with the progression of a number of other pathological findings, including asthma, allergic inflammation, atherosclerosis, and fibrosis (4, 33).”
BackgroundSallusto, F., Cella, M., Danieli, C., & Lanzavecchia, A. (1995) · The Journal of experimental medicine · doi:10.1084/jem.182.2.389 · Cited by 2,500
Cancer Treatment by Targeted Drug Delivery to Tumor Vasculature in a Mouse Model
Arap, W., Pasqualini, R., & Ruoslahti, E. (1998) · Science · doi:10.1126/science.279.5349.377 · Cited by 2,054
Macrophages, innate immunity and cancer: balance, tolerance, and diversity
Mantovani, A., & Sica, A. (2010) · Current Opinion in Immunology · doi:10.1016/j.coi.2010.01.009 · Cited by 1,484
Tumor-Associated Macrophages and Survival in Classic Hodgkin's Lymphoma
Steidl, C., Lee, T., Shah, S. P., Farinha, P., Han, G., Nayar, T., Delaney, A., Jones, S. J., Iqbal, J., Weisenburger, D. D., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa0905680 · Cited by 1,262
Organ targeting In vivo using phage display peptide libraries
Pasqualini, R., & Ruoslahti, E. (1996) · Nature · doi:10.1038/380364a0 · Cited by 1,221
Low, P. S., Henne, W. A., & Doorneweerd, D. D. (2008) · Accounts of Chemical Research · doi:10.1021/ar7000815 · Cited by 1,173
Bone Marrow-Derived Macrophages (BMM): Isolation and Applications
Weischenfeldt, J., & Porse, B. (2008) · Cold Spring Harbor Protocols · doi:10.1101/pdb.prot5080 · Cited by 955
Anti-cancer activity of targeted pro-apoptotic peptides
Ellerby, H. M., Arap, W., Ellerby, L. M., Kain, R., Andrusiak, R., Rio, G. D., Krajewski, S., Lombardo, C. R., Rao, R., Ruoslahti, E., et al. (1999) · Nature Medicine · doi:10.1038/12469 · Cited by 936
Ross, J. F., Chaudhuri, P. K., & Ratnam, M. (1994) · Cancer · doi:10.1002/1097-0142(19940501)73:9<2432::aid-cncr2820730929>3.0.co;2-s · Cited by 891
CCL18 from Tumor-Associated Macrophages Promotes Breast Cancer Metastasis via PITPNM3
Chen, J., Yao, Y., Gong, C., Yu, F., Su, S., Chen, J., Liu, B., Deng, H., Wang, F., Lin, L., et al. (2011) · Cancer Cell · doi:10.1016/j.ccr.2011.02.006 · Cited by 641
Zeisberger, S. M., Odermatt, B., Marty, C., Zehnder-Fjällman, A. H. M., Ballmer-Hofer, K., & Schwendener, R. A. (2006) · British Journal of Cancer · doi:10.1038/sj.bjc.6603240 · Cited by 623
Targeting tumor-associated macrophages as a novel strategy against breast cancer
Luo, Y. (2006) · Journal of Clinical Investigation · doi:10.1172/jci27648 · Cited by 552
Macrophages and cathepsin proteases blunt chemotherapeutic response in breast cancer
Shree, T., Olson, O. C., Elie, B. T., Kester, J. C., Garfall, A. L., Simpson, K., Bell-McGuinn, K. M., Zabor, E. C., Brogi, E., & Joyce, J. A. (2011) · Genes & Development · doi:10.1101/gad.180331.111 · Cited by 541 · cited 1×
“Furthermore, TAMs can contribute to chemotherapy resistance in tumors (31, 32).”
BackgroundKim, E. Y., Battaile, J. T., Patel, A. C., You, Y., Agapov, E., Grayson, M. H., Benoit, L. A., Byers, D. E., Alevy, Y., Tucker, J., et al. (2008) · Nature Medicine · doi:10.1038/nm1770 · Cited by 523
Jinushi, M., Chiba, S., Yoshiyama, H., Masutomi, K., Kinoshita, I., Dosaka-Akita, H., Yagita, H., Takaoka, A., & Tahara, H. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1106645108 · Cited by 479
Detection of colonic dysplasia in vivo using a targeted heptapeptide and confocal microendoscopy
Hsiung, P.-L., Hardy, J., Friedland, S., Soetikno, R., Du, C. B., Wu, A. P., Sahbaie, P., Crawford, J. M., Lowe, A. W., Contag, C. H., et al. (2008) · Nature Medicine · doi:10.1038/nm1692 · Cited by 444
Sinha, P., Clements, V. K., & Ostrand-Rosenberg, S. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-0045 · Cited by 317
Cooperative nanomaterial system to sensitize, target, and treat tumors
Park, J.-H., von Maltzahn, G., Xu, M. J., Fogal, V., Kotamraju, V. R., Ruoslahti, E., Bhatia, S. N., & Sailor, M. J. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0909565107 · Cited by 307
Role of infiltrated leucocytes in tumour growth and spread
Lin, E. Y., & Pollard, J. W. (2004) · British Journal of Cancer · doi:10.1038/sj.bjc.6601705 · Cited by 278
A proapoptotic peptide for the treatment of solid tumors.
Mai, J., Mi, Z., Kim, S.-H., Ng, B., & Robbins, P. D. (2001) · PubMed · Cited by 247
Welford, A. F., Biziato, D., Coffelt, S. B., Nucera, S., Fisher, M., Pucci, F., Di Serio, C., Naldini, L., De Palma, M., Tozer, G. M., et al. (2011) · Journal of Clinical Investigation · doi:10.1172/jci44562 · Cited by 228
Cell-specific delivery of genes with glycosylated carriers
HASHIDA, M. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(01)00209-5 · Cited by 171
Macrophage-Specific RNA Interference Targeting via “Click”, Mannosylated Polymeric Micelles
Yu, S. S., Lau, C. M., Barham, W. J., Onishko, H. M., Nelson, C. E., Li, H., Smith, C. A., Yull, F. E., Duvall, C. L., & Giorgio, T. D. (2013) · Molecular Pharmaceutics · doi:10.1021/mp300434e · Cited by 166
Strategies to prolong the plasma residence time of peptidedrugs
Pollaro, L., & Heinis, C. (2010) · MedChemComm · doi:10.1039/c0md00111b · Cited by 161
Unique Proteomic Signatures Distinguish Macrophages and Dendritic Cells
Becker, L., Liu, N.-C., Averill, M. M., Yuan, W., Pamir, N., Peng, Y., Irwin, A. D., Fu, X., Bornfeldt, K., & Heinecke, J. W. (2012) · PLoS ONE · doi:10.1371/journal.pone.0033297 · Cited by 115
Principal references used in Chemical Society Publications as from January, 1960
(1959) · Annual Reports on the Progress of Chemistry · doi:10.1039/ar9595600461 · Cited by 94
Hamann, F. M., Brehm, R., Pauli, J., Grabolle, M., Frank, W., Kaiser, W. A., Fischer, D., Resch‐Genger, U., & Hilger, I. (2011) · Molecular Imaging · doi:10.2310/7290.2011.00005 · Cited by 40
Segers, F. M., Yu, H., Molenaar, T. J. M., Prince, P., Tanaka, T., van Berkel, T. J. C., & Biessen, E. A. L. (2012) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.111.235358 · Cited by 32
Cited by
Tumor-Associated Macrophages as Major Players in the Tumor Microenvironment
Chanmee, T., Ontong, P., Konno, K., & Itano, N. (2014) · Cancers · doi:10.3390/cancers6031670 · Cited by 1,538
Lin, Y., Xu, J., & Lan, H. (2019) · Journal of Hematology & Oncology · doi:10.1186/s13045-019-0760-3 · Cited by 1,398
“M2 macrophage-targeting peptide (M2pep), just as implied by the name, is such a construct discovered recently [143].”
BackgroundConcepts of nanoparticle cellular uptake, intracellular trafficking, and kinetics in nanomedicine
Donahue, N. D., Acar, H., & Wilhelm, S. (2019) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2019.04.008 · Cited by 944
Progress in tumor-associated macrophage (TAM)-targeted therapeutics
Ngambenjawong, C., Gustafson, H. H., & Pun, S. H. (2017) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2017.04.010 · Cited by 840
Self-citationGinseng-derived nanoparticles alter macrophage polarization to inhibit melanoma growth
Cao, M., Yan, H., Han, X., Weng, L., Wei, Q., Sun, X., Lu, W., Wei, Q., Ye, J., Cai, X., et al. (2019) · Journal for ImmunoTherapy of Cancer · doi:10.1186/s40425-019-0817-4 · Cited by 552
Metadata
- Authors
- Cieslewicz, M., Tang, J., Yu, J. L., Cao, H., Zavaljevski, M., Motoyama, K., Lieber, A., Raines, E. W., & Pun, S. H.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 2013-09-17
- Volume
- 110
- Issue
- 40
- Pages
- 15919-15924
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W2093619322
- Cited by
- 314
- References
- 35
- FWCI
- 8.18
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.